Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Digital therapy for managing COPD

Official title: Digital Therapy in Self-management of Chronic Obstructive Pulmonary Disease Patients:A Prospective, Open-labled, Multicenter Randomized Controlled Clinical Study.

Run by China-Japan Friendship Hospital · NCT06776601 · Data updated 2026-11-12

This study tests a digital therapy program designed to help people with COPD use their inhalers correctly and stick to their medication to see if it can reduce flare-ups and improve their health.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment600 (estimated)
SponsorChina-Japan Friendship Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJuly 18, 2024
Main results expectedSeptember 18, 2025
Study endsDecember 30, 2025
Registry record updatedJanuary 15, 2025
Trial IDNCT06776601 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 40 and above with a diagnosis of COPD who have experienced severe exacerbations in the past year but are currently stable.

Probably not a fit

Patients with unstable comorbidities or recent surgeries, as well as pregnant or lactating women, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project implements a comprehensive digital therapy intervention for patients with Chronic Obstructive Pulmonary Disease (COPD). It includes an inhalation technique assessment device, an electronic inhalant medication monitoring device, and digital software to help patients use their inhalers correctly. The intervention aims to enhance medication adherence, manage behavior data, and provide personalized reminders and feedback to patients. The goal is to reduce acute exacerbations of COPD and improve overall disease management.

Why it matters

Potential benefit: If successful, this intervention could significantly improve medication adherence and reduce the frequency of acute exacerbations in COPD patients.

How similar studies have gone: Other studies have shown promise in using digital interventions for chronic disease management, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients diagnosed with COPD
2. Aged 40 and above
3. Had one or more severe acute exacerbations in the past year, and be in stable condition for the last 4 weeks
4. Can operate a smartphone proficiently
5. Take inhalation medication suits for the inhalation monitoring device as treatment
6. Fully understand and be willing to sign the informed consent form

Exclusion Criteria:

1. Certain comorbidities (e.g. unstable coronary complications)
2. Undergone thoracic, abdominal or ophthalmic surgery in recent 3 months
3. Pregnant or lactating women
4. ABS allergy history

Where it's running

  • China Japan Friendship Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.